comprehensive -WSS

comprehensive

author：hotspot 2025-09-28 20:44:34 - browse：39

a person uses a smart phone with both fingers in the dark – first opinion coverage from STAT — Adobe

In May, a National Public Radio story asked, “Can a chatbot help people with eating disorders as well as another human?”

It focused on a chatbot that we developed to prevent eating disorders and help people with body image concerns and who are otherwise not likely to have access to other resources. We’ve committed our careers to increasing detection of eating disorders and access to care, and we received research funding from the National Eating Disorders Association (NEDA) to create and evaluate a chatbot called Tessa in hopes of preventing eating disorders and helping to address the problem that once individuals develop eating disorders, less than 20% ever receive any care.

The NPR story and coverage that followed led to a tremendous backlash for a couple of reasons. Some of those reasons are fair and are related to a technical problem — more on that in a minute.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： The health care issue Democrats can’t solve: hospital reform

WSS

Coloradans with cystic fibrosis could lose access to Trikafta

What we owe ALS patients — and why one company fell short

Bill would allow buprenorphine prescription for addiction via telehealth

Life sciences investors close nearly $6 billion in new funds

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Kidney transplant patients stopped immunosuppressants in trial

explore

comprehensive

focus

Anesthesiologist group: stop taking Ozempic before surgery

Life sciences investors close nearly $6 billion in new funds

Supreme Court strikes down use of affirmative action

The biotech scorecard for Q4: 16 stock

Wildfire smoke exposes gaps in outdoor worker protections

Medicare proceeds with plan to claw back hospital funds

Duchenne breakthrough therapy leaves behind pioneering families

Gene therapy’s promise and the high cost of hope

The high cost of giving birth even with insurance

After Sarepta trial failure, Duchenne families brace for more debate

focus

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Lawsuit highlights wrinkle for disputes over surprise medical bills

Bill would allow buprenorphine prescription for addiction via telehealth

Key Senate panel to consider PBM, drug pricing reform package

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

explore

hotspot

knowledge

hotspot